The Future of Psychedelic Medicine
Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
People globally are affected by a form of depression.
Dollars lost annually in global workforce productivity due to depression and anxiety.
Formulas standardized across clinical studies of psychedelic compounds.
HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
HAVN LIFE PROVIDES CORPORATE UPDATE
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces that the Ontario and British Columbia …
HAVN Life Announces Retail Listing With Loblaws Company Ltd.
The Company’s line of plant and mushroom-based natural health products will be available at LCL grocery banners across Canada Vancouver, BC – Havn Life Sciences …
HAVN LIFE ANNOUNCES BOARD AND MANAGEMENT CHANGES
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Mr. Gary Leong …